A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...

Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

The rationale for the study, according to the authors, is that “Nearly 2% of the US population received a prescription for semaglutide in 2023. There has been a recent concern that this drug and other ...

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...

Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...